Our data suggests that the multitarget compound cetirizine—an inhibitor of MAGL and H1 antagonist—might be an effective therapeutic approach in osteoarthritis, reducing both pain, the central symptom of the disease, and inflammation, a contributor to tissular degeneration. Here, MGLL is linked to osteoarthritis.